Human trabecular meshwork cells express functional serotonin-2A (5HT 2A) receptors: Role in IOP reduction

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 9, 2006, Pages 4001-4010

  Sharif, Najam A ^a   Kelly, Curtis R ^a   McLaughlin, Marsha ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 METHOXY N,N DIMETHYLTRYPTAMINE; 5 METHOXYTRYPTAMINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; ALPHA METHYLSEROTONIN; CALCIUM ION; MESSENGER RNA; PHOSPHATIDYLINOSITIDE; SEROTONIN; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C ANTAGONIST; SEROTONIN DERIVATIVE; 4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE; AMPHETAMINE DERIVATIVE; CALCIUM; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); INOSITOL PHOSPHATE; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MACACA; MALE; NONHUMAN; OCULOPLETHYSMOGRAPHY; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRABECULAR MESHWORK; ADOLESCENT; ADULT; AGED; ANIMAL; CHILD; CHO CELL; CRICETULUS; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HAMSTER; INFANT; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMPHETAMINES; ANIMALS; CALCIUM; CHILD; CHILD, PRESCHOOL; CHO CELLS; CRICETINAE; CRICETULUS; FEMALE; GENE EXPRESSION REGULATION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; INFANT; INOSITOL PHOSPHATES; INTRAOCULAR PRESSURE; MACACA FASCICULARIS; MALE; MIDDLE AGED; OCULAR HYPERTENSION; RECEPTOR, SEROTONIN, 5-HT2A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEROTONIN AGONISTS; TRABECULAR MESHWORK; TRANSFECTION;

EID: 33748434172     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0062     Document Type: Article

References (45)

1. Quigley HA. Open-angle glaucoma. N Engl J Med. 1993;328:1097-1106.
2. Hellberg MR, Sallee VL, McLaughlin MA, et al. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J Ocul Pharmacol Ther. 2001;17:421-432.
3. 2α analogue. Adv Prostaglandin Thrombox Leukotr Res. 1995;23:513-518.
4. Sugrue MF. New approaches to antiglaucoma therapy. J Med Chem. 1997;40:2793-2809.
5. Clark AC, Yorio T. Ophthalmic drug discovery. Nat Rev Drug Discov. 2003;2:448-459.
6. Hoyer D, Clarke DE, Fozard JR, et al. VII International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharm Rev. 1994;46:157-203.
7. Martin XD, Brennan MC, Lichter, PR. Serotonin in human aqueous humor. Ophthalmol. 1988;95:1221-1226.
8. Veglio F, De Sanctis U, Schiavone D, et al. Evaluation of serotonin levels in human aqueous humor. Ophthalmologica. 1998;212:160-163.
9. Martin XD, Malina HZ, Brennan MC, Hendrickson PH, and Lichter PR. The ciliary body: the third organ found to synthesize indoleamines in humans. Eur J Ophthalmol. 1992;2:67-72.
10. Tobin AB, Unger W, Osborne NN. Evidence for presence of serotonergic nerves and receptors in the iris-ciliary body complex of the rabbit. J Neurosci. 1988;8:3713-3721.
11. 3H]-5-hydroxytryptamine binding to iris-ciliary body tissue of the rabbit. Invest Ophthalmol Vis Sci. 1995;36:2238-2245.
12. 1-adrenoceptor antagonist, lowers intraocular pressure in NZW rabbits. Curr Eye Res. 2001;23:144-153.
13. Wang RF, Lee PY, Mittag TW, Podos SM, Serle JB. Effect of methylurapidil, an alpha-1a-adrenergic antagonist and 5-hydroxytrptamine 1A agonist, on aqueous humor dynamics in monkeys and rabbits. Curr Eye Res. 1997;16:769-775.
14. 1A Receptor agonist 8-OH-DPAT lowers intraocular pressure in normotensive NZW rabbits. Exp Eye Res. 1999;69:587-593.
15. Chu TC, Ogidigben MJ, Potter DE. 8-OH-DPAT-induced ocular hypotension: sites and mechanisms of action. Exp Eye Res. 1999;69:227-238.
16. 2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys. J Pharmacol Exp Ther. 2003;306:301-309.
17. 1-agonist 5-CT intraocular pressure in rabbits. Invest Ophthalmol Vis Sci. 1993;34:3035-3042.
18. Chang FW, Burke JA, Potter, DE. Mechanism of ocular hypotensive action of ketanserin. J Ocular Pharmacol. 1985;1:137-147.
19. Krootila K, Palkama A, Uusitalo H. Effect of serotonin and its antagonist (ketanserin) on intraocular pressure in the rabbit. J Ocul Pharmacol. 1987;3:279-290.
20. Mastropasqua L, Costagliola C, Ciancaglini M, Carpineto P, Gallenga PE. Ocular hypotensive effect of ketanserin in patients with primary open angle glaucoma. Acta Ophthalmol Scand Suppl. 1997;224:24-25.
21. Chidlow G, Hiscott PS, Osborne NN. Expression of serotonin receptor mRNAs in human ciliary body: a polymerase chain reaction study. Graefes Arch Clin Exp Ophthalmol. 2004;242:259-264.
22. 2, receptor subtypes. J Pharmacol Exp Ther. 2002;303:815-822.
23. Sharif NA, Wiernas TK, Howe WE, Griffin BW, Offord EA, Pfeifer AMA. Human corneal epithelial cell functional responses to inflammatory agents and their antagonists. Invest Ophthalmol Vis Sci. 1998;39:2562-2571.
24. Sharif NA, Senchyna, M, Xu SX. Pharmacological and molecular biological (RT-PCR) characterization of functional TP prostanoid receptors in immortalized human non-pigmented ciliary epithelial cells. J Ocular Pharmacol Ther. 2002;18:141-162.
25. 2+ mobilization studies. Prostaglandins Leukot Essent Fatty Acids. 2003;68:27-33.
26. 2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors. J Pharmacol Exp Tber. 2003;304:238-245.
27. Sharif NA, Xu SX, Crider JY, McLaughlin M, Davis TL. Levobetaxolol (Betaxon™) and other beta-adrenergic antagonists: preclinical pharmacology, IOP-lowering activity and sites of action in human eyes. J Ocul Pharmacol Ther. 2001;17:305-317.
28. 2 receptor subtypes. Eur J Pharmacol. 2001;414:23-30.
29. 2C receptors in CHO-K1 cells. Br J Pharmacol. 1999;128:13-20.
30. 2C receptors in functional studies. Pharmacol Rev Commun. 1997;9:259-268.
31. 2B receptor: evidence for species differences. J Pharmacol and Exp Ther. 1996;276:720-726.
32. Gabelt BT, Millar CJ, Kiland JA, Peterson JA, Seeman JL, Kaufman PL. Effects of serotonergic compounds on aqueous humor dynamics in monkeys. Curr Eye Res. 2001;23:120-127.
33. 2 receptor-mediated phospinositide hydrolysis in bovine ciliary epithelium. J Ocul Pharmacol Ther. 2003;19:55-62.
34. 3 receptors in the bovine ciliary muscle. Eur J Pharmacol. 2003;464:69-74.
35. 3H] norepinephrine release from isolated mammalian iris-ciliary bodies. J Ocular Pharmacol Ther. 2002;18:339-348.
36. 7) autoreceptors. Exp Eye Res. 2001;73:59-67.
37. Takat D, Guler C, Ariel M, Topalkara A, Erdogan H. Effect of ketanserin administration on intraocular pressure. Ophthalmologica. 2001;215:419-423.
38. Costagliola C, Iuliano G, Rinaldi M, Russo V, Scibelli G, Mastropasqua L. Effect of topical ketanserin administration on intraocular pressure. Br J Pharmacol. 1993;77:344-348.
39. Chiou GC, Li BH. Ocular hypotensive actions of serotonin antagonist-ketanserin analogs. J ocular Pharmacol Ther. 1992;8:11-21.
40. Oshika T, Araie M, Sugiyama T, Nakajima M, Azuma I. Effect of bunazosin hydrochloride on intraocular pressure and aqueous humor dynamics in normotensive human eyes. Arch Ophthalmol. 1991;109:1569-1574.
41. 2A antagonist with a favorable CNS safety profile. J Pharmacol Exp The. 1996;277:968-981.
42. 2C receptor antagonist. Neuropharmacology. 1997;36:609-620.
43. Gabelt BT, Okka M, Dean, TR, Kaufman PL. Aqueous humor dynamics in monkeys after topical R-DOI. Invest Ophthalmol Vis Sci. 2005;46:4691-4696.
44. 2α and fluprostenol on trabecular meshwork contractility. Invest Ophthalmol Vis Sci. 2006;47:938-945.
45. Sharif NA, Kelly CR, Crider JY. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone and other FP prostaglandin receptor agonist analogues. Invest Ophthalmol Vis Sci. 2003;44:715-721.